Skip to main content
Fig. 4 | Cardio-Oncology

Fig. 4

From: The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials

Fig. 4

Forest plots of the secondary efficacy outcomes, (1: Left ventricular ejection fraction (LVEF) change, 2: Global longitudinal strain (GLS) change, 3: Stroke volume (SV) change, 4: Left ventricular end-diastolic volume (LVEDV) change, 5: Left ventricular end-systolic volume (LVESV) change, 6: E/A ratio change, and 7: Cardiac output (CO) change), MD: mean difference, CI: confidence interval

Back to article page